Senti Biosciences is trading at $0.35, up 10.52%, alongside a 2.07% biotech-sector gain on September 23, 2026; the move appears primarily sector-driven, with no new company-specific catalyst identified.
- Sector optimism reflects a major AI drug-discovery collaboration and positive clinical developments.
- Broader market indexes are modestly lower, making biotech outperformance more notable.